Human immunoglobulin G mediates protective immunity and identifies protective antigens against larval Strongyloides stercoralis in mice

Journal of Infectious Diseases

Volumn 189, Issue 7, 2004, Pages 1282-1290

  Kerepesi, Laura A ^a   Nolan, Thomas J ^b   Schad, Gerhard A ^b   Lustigman, Sara ^d   Herbert, De'Broski R ^a,e   Keiser, Paul B ^c   Nutman, Thomas B ^c   Krolewiecki, Alejandro J ^a,f   Abraham, David ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d NEW YORK BLOOD CENTER   (United States)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

^f FUNDACIÓN HUÉSPED   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COMPLEMENT; IMMUNOGLOBULIN G; PARASITE ANTIGEN; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY; EOSINOPHIL; GRANULOCYTE; HUMAN; IMMUNITY; LARVA; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SERUM; STRONGYLOIDES STERCORALIS; VACCINE PRODUCTION;

ANIMALS; ANTIGENS, HELMINTH; BLOTTING, WESTERN; CHROMATOGRAPHY, AFFINITY; COMPLEMENT C3; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, IMMUNOELECTRON; RECEPTORS, IGG; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 1842503146     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/382484     Document Type: Article

References (44)

1. Grove DI. Human strongyloidiasis. Adv Parasitol 1996; 38:251-309.
2. Brandt de Oliveira R, Voltarelli JC, Meneghelli UG. Severe strongyloidiasis associated with hypogammaglobulinaemia. Parasite Immunol 1981; 3:165-9.
3. Bezjak B. Immunoglobulin studies in strongyloidiasis with special reference to raised serum IgE levels: preliminary communication. Am J Trop Med Hyg 1975; 24:945-8.
4. Atkins NS, Lindo JF, Lee MG, et al. Humoral responses in human strongyloidiasis: correlations with infection chronicity. Trans R Soc Trop Med Hyg 1997; 91:609-13.
5. Atkins NS, Conway DJ, Lindo JF, Bailey JW, Bundy DA. L3 antigen-specific antibody isotype responses in human strongyloidiasis: correlations with larval output Parasite Immunol 1999; 21:517-26.
6. Genta RM, Douce RW, Walzer PD. Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. J Clin Microbiol 1986; 23:1099-103.
7. Brindley PJ, Gam AA, Pearce EJ, Poindexter RW, Neva FA. Antigens from the surface and excretions/secretions of the filariform larva of Strongyloides stercoralis. Mol Biochem Parasitol 1988; 28:171-80.
8. Conway DJ, Bailey JW, Lindo JF, Robinson RD, Bundy DA, Bianco AE. Serum IgG reactivity with 41-, 31-, and 28-kDa larval proteins of Strongyloides stercoralis in individuals with strongyloidiasis. J Infect Dis 1993; 168:784-7.
9. Lindo JF, Conway DJ, Atkins NS, Bianco AE, Robinson RD, Bundy DA. Prospective evaluation of enzyme-linked immunosorbent assay and immunoblot methods for the diagnosis of endemic Strongyloides stercoralis infection. Am J Trop Med Hyg 1994; 51:175-9.
10. Ramachandran S, Thompson RW, Gam AA, Neva FA. Recombinant cDNA clones for immunodiagnosis of strongyloidiasis. J Infect Dis 1998; 177:196-203.
11. Robinson RD, Undo JF, Neva FA, et al. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type 1 infections in Jamaica. J Infect Dis 1994; 169:692-6.
12. Porto AF, Neva FA, Bittencourt H, et al. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. Parasite Immunol 2001; 23:503-7.
13. Porto AF, Oliveira Filho J, Neva FA, et al. Influence of human T-cell lymphocytetropic virus type 1 infection on serologic and skin tests for strongyloidiasis. Am J Trop Med Hyg 2001; 65:610-3.
14. Gotuzzo E, Terashima A, Alwarez H, et al. Strongyloides stercoralis hyperinfection associated with human T cell lymphotropic virus type-1 infection in Peru. Am J Trop Med Hyg 1999; 60:146-9.
15. Newton RC, Limpuangthip P, Greenberg S, Gam A, Neva FA. Strongyloides stercoralis hyperinfection in a carrier of HTLV-1 virus with evidence of selective immunosuppression. Am J Med 1992; 92:202-8.
16. Phelps KR, Ginsberg SS, Cunningham AW, Tschachler E, Dosik H. Case report: adult T-cell leukemia/lymphoma associated with recurrent strongyloides hyperinfection. Am J Med Sci 1991; 302:224-8.
17. Adedayo AO, Grell GA, Bellot P. Case study: fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1 infection. Am J Trop Med Hyg 2001; 65:650-1.
18. Abraham D, Rotman HL, Haberstroh HF, et al. Strongyloides stercoralis: protective immunity to third-stage larvae in BALB/cByJ mice. Exp Parasitol 1995; 80:297-307.
19. Brigandi RA, Rotman HL, Yutanawiboonchai W, et al. Strongyloides stercoralis: role of antibody and complement in immunity to the third stage of larvae in BALB/cByJ mice. Exp Parasitol 1996; 82:279-89.
20. Ligas JA, Kerepesi LA, Galioto AM, et al. Specificity and mechanism of immunoglobulin M (IgM)-and IgG-dependent protective immunity to larval Strongyloides stercoralis in mice. Infect Immun 2003; 71:6835-43.
21. Herbert DR, Lee JJ, Lee NA, Nolan TJ, Schad GA, Abraham D. Role of IL-5 in innate and adaptive immunity to larval Strongyloides stercoralis in mice. J Immunol 2000; 165:4544-51.
22. Rotman HL, Schnyder-Candrian S, Scott P, Nolan TJ, Schad GA, Abraham D. IL-12 eliminates the Th-2 dependent protective immune response of mice to larval Strongyloides stercoralis. Parasite Immunol 1997; 19:29-39.
23. Rotman HL, Yutanawiboonchai W, Brigandi RA, et al. Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third-stage larvae in BALB/cByJ mice. Exp Parasitol 1996; 82:267-78.
24. Herbert DR, Nolan TJ, Schad GA, Lustigman S, Abraham D. Immunoaffinity-isolated antigens induce protective immunity against larval Strongyloides stercoralis in mice. Exp Parasitol 2002; 100:112-20.
25. Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV. FcR gamma chain deletion results in pleiotrophic effector cell defects. Cell 1994; 76:519-29.
26. Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature 1996; 379:346-9.
27. + B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity 1996; 4:15-24.
28. Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1989; 245:308-10.
29. Brigandi RA, Rotman HL, Nolan TJ, Schad GA, Abraham D. Chronicity in Strongloides stercoralis infections: dichotomy of the protective immune response to infective and autoinfective larvae in a mouse model. Am J Trop Med Hyg 1997; 56:640-6.
30. Irvine M, Huima T, Prince AM, Lustigman S. Identification and characterization of an Onchocerca volvulus cDNA clone encoding a highly immunogenic calponin-like protein. Mol Biochem Parasitol 1994; 65:135-46.
31. Jwo I, LoVerde PT. Fractionated sera from Schistosoma mansoni-infected patients confers passive protection in mice. Am J Trop Med Hyg 1989; 41:553-62.
32. Jwo J, LoVerde PT. The ability of fractionated sera from animals vaccinated with irradiated cercariae of Schistosoma mansoni to transfer immunity to mice. J Parasitol 1989; 75:252-60.
33. Abraham-D, Grieve RB. Passive transfer of protective immunity to larval Dirofilaria immitis from dogs to BALB/c mice. J Parasitol 1991; 77:254-7.
34. Rajapakse RP, Lloyd S, Fernando ST. The effect of serum and colostrum immunoglobulins from buffaloes infected with Toxocara vitulorum on T. vitulorum larvae in vitro and in vivo in mice. Parasitol Res 1994; 80:426-30.
35. Genta RM, Lillibridge JP. Prominence of IgG4 antibodies in the human responses to Strongloides stercoralis infection. J Infect Dis 1989; 160:692-9.
36. Murrell KD. Protective role of immunoglobulin G in immunity to Strongyloides ratti. J Parasitol 1981; 67:167-73.
37. Nutman TB, Ottesen EA, leng S, et al. Eosinophilia in Southeast Asian refugees: evaluation at a referral center. J Infect Dis 1987; 155:309-13.
38. Gutierrez Y, Bhatia P, Garbadawala ST, Dobson JR, Wallace TM, Carey TE. Strongyloides stercoralis eosinophilic granulomatous enterocolitis. Am J Surg Pathol 1996; 20:603-12.
39. Carvalho EM, Andrade TM, Andrade JA, Rocha H. Immunological features in different clinical forms of strongyloidiasis. Trans R Soc Trop Med Hyg 1983; 77:346-9.
40. Lambroza A, Dannenberg AJ. Eosinophilic ascites due to hyperinfection with Strongyloides stercoralis. Am J Gastroenterol 1991; 86:89-91.
41. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 1981; 3:397-407.
42. Ober RJ, Radu CG, Ghetie V, Ward ES. Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. Int Immunol 2001; 13:1551-9.
43. de Messias IJ, Genta RM, Mohren WD. Adherence of monocytes and polymorphonuclear cells to infective larvae of Strongyloides stercoralis after complement activation. J Parasitol 1994; 80:267-74.
44. Shin EH, Osada Y, Sagara H, Takatsu K, Kojima S. Involvement of complement and fibronectin in eosinophil-mediated damage to Nippostrongylus brasiliensis larvae. Parasite Immunol 2001; 23:27-37.